We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M Turnover 23.21%
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+7.86%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$234M
AUM Growth
-$5.63M
Cap. Flow
-$22.7M
Cap. Flow %
-9.71%
Top 10 Hldgs %
77.03%
Holding
114
New
24
Increased
15
Reduced
9
Closed
6
Avg Time Held
1.8 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$1.24M
2
ATCO
Atlas Corp.
ATCO
+$963K
3
XRN.PRA icon
Chiron Real Estate Inc Series A Preferred Stock
XRN.PRA
+$871K
4
KMB icon
Kimberly-Clark
KMB
+$733K
5
RXDX
Ignyta, Inc.
RXDX
+$698K

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$25.4M
2
AGN
Allergan plc
AGN
+$2.3M
3
PFE icon
Pfizer
PFE
+$1.93M
4
ABBV icon
AbbVie
ABBV
+$1.35M
5
DD icon
Du Pont De Nemours E I
DD
+$1.19M

Sector Composition

Rank Sector Weight
1 Healthcare 70.4%
2 Financials 8.46%
3 Technology 4.23%
4 Real Estate 3.89%
5 Industrials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LGND icon
1
Ligand Pharmaceuticals
LGND
$5.85B
$109M 46.45%
1,279,354
-320,600
-20% -$25.4M
2013 Q2
17 quarters
PFE icon
2
Pfizer
PFE
$168B
$34.9M 14.93%
1,031,525
-60,078
-6% -$1.93M
2013 Q2
17 quarters
CFFN icon
3
Capitol Federal Financial
CFFN
$1.01B
$10.1M 4.34%
690,400
– –
2013 Q2
17 quarters
MSFT icon
4
Microsoft
MSFT
$3.91T
$5.12M 2.19%
68,750
– –
2013 Q2
17 quarters
ABBV icon
5
AbbVie
ABBV
$504B
$4.67M 1.99%
52,500
-17,700
-25% -$1.35M
2015 Q2
9 quarters
APC icon
6
DELISTED
Anadarko Petroleum
APC
$3.94M 1.69%
80,760
– –
2013 Q2
17 quarters
AAPL icon
7
Apple
AAPL
$5.01T
$3.86M 1.65%
100,200
– –
2013 Q2
17 quarters
IRDM icon
8
Iridium Communications
IRDM
$4.69B
$3.48M 1.49%
338,000
– –
2014 Q2
13 quarters
DAL icon
9
Delta Air Lines
DAL
$50.1B
$2.77M 1.19%
57,500
– –
2015 Q4
7 quarters
DD icon
10
DuPont de Nemours
DD
$17.7B
$2.61M 1.11%
14,865
+7,441
+100% +$1.24M
2015 Q1
10 quarters
OSG icon
11
Octave Specialty Group
OSG
$209M
$2.51M 1.07%
145,426
-25,000
-15% -$462K
2013 Q2
17 quarters
HHH icon
12
Howard Hughes
HHH
$4.12B
$2.36M 1.01%
20,980
+5,245
+33% +$599K
2017 Q2
1 quarter
JPM icon
13
JPMorgan Chase
JPM
$900B
$2.2M 0.94%
23,050
– –
2013 Q2
17 quarters
CXW icon
14
CoreCivic
CXW
$3.03B
$2.01M 0.86%
75,000
– –
2016 Q4
3 quarters
AVDL
15
DELISTED
Avadel Pharmaceuticals
AVDL
$1.67M 0.71%
158,555
+32,092
+25% +$306K
2015 Q4
7 quarters
CHCT icon
16
Community Healthcare Trust
CHCT
$381M
$1.62M 0.69%
60,000
– –
2015 Q2
9 quarters
KHC icon
17
The Kraft Heinz Company
KHC
$27.8B
$1.23M 0.53%
15,900
+4,000
+34% +$335K
2015 Q3
8 quarters
AB icon
18
AllianceBernstein
AB
$3.19B
$1.23M 0.52%
50,500
– –
2013 Q2
17 quarters
CNQ icon
19
Canadian Natural Resources
CNQ
$111B
$1.08M 0.46%
66,059
– –
2017 Q2
1 quarter
ENFC
20
DELISTED
Entegra Financial Corp.
ENFC
$1M 0.43%
40,250
– –
2014 Q4
11 quarters
ATCO
21
DELISTED
Atlas Corp.
ATCO
$993K 0.42%
+140,000
New +$963K
2017 Q3
0 quarters
DOC icon
22
DELISTED
PHYSICIANS REALTY TRUST
DOC
$989K 0.42%
55,800
– –
2013 Q3
16 quarters
JNJ icon
23
Johnson & Johnson
JNJ
$615B
$946K 0.4%
7,280
– –
2013 Q2
17 quarters
CPRX icon
24
DELISTED
Catalyst Pharmaceutical
CPRX
$920K 0.39%
365,110
+9,360
+3% +$25.7K
2017 Q1
2 quarters
GSK icon
25
GSK
GSK
$99.4B
$918K 0.39%
18,080
– –
2014 Q4
11 quarters
1
2 3 4 5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q3 2017 Portfolio in Review

As of Q3 2017, David M. Knott held 114 positions worth $234M, down 2.4% from $240M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

David M. Knott withdrew a net $22.7M in Q3 2017, closing 6 positions and reducing 9 holdings. Its most notable exit was Allergan plc, an estimated $2.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, down from 73% a quarter earlier, followed by Financials and Technology.

Against the trend, David M. Knott opened a new position in Atlas Corp. worth $993K.

  • David M. Knott's largest Q3 2017 buy was Atlas Corp.: 140,000 shares worth $993K.
  • David M. Knott added most to DuPont de Nemours in Q3 2017, an estimated $1.24M increase.
  • David M. Knott's biggest Q3 2017 reduction was Ligand Pharmaceuticals, cutting an estimated $25.4M.
  • David M. Knott fully exited Allergan plc in Q3 2017, selling an estimated $2.3M.
  • David M. Knott's ten largest holdings make up 77% of its $234M portfolio in Q3 2017.
  • David M. Knott opened 24 new positions and closed 6 in Q3 2017.
  • David M. Knott's portfolio value fell 2.4% quarter-over-quarter to $234M.

Based on David M. Knott's 13F filing for Q3 2017, filed 13 Nov 2017.